When It Comes to Alzheimer’s, It Helps to Have a Teams
If you or someone you love is becoming increasingly forgetful, has difficulty in planning and problem-solving, or gets lost in familiar places, these could be signs of mild cognitive impairment or early Alzheimer’s disease. Alzheimer’s is a brain disease that causes memory loss that disrupts daily life—it’s critical to get checked out soon.
Don’t walk the journey alone. Find care and support not only from your loved ones, but also from doctors and their healthcare teams through clinical research studies.
Consider joining one of the evoke clinical research studies today.
You or a loved one may be able to participate in the evoke studies if:
- You may have early Alzheimer’s disease (you may not know if you have early Alzheimer’s disease)
- You are between 55 and 85 years old
- You have a study partner (a next of kin or someone you have a close relationship with), who is willing to take part in the studies and share information about you
If you are interested in participating, the study doctor or staff will review additional criteria. Qualified participants will receive all studies-related care at no cost.
About Early Alzheimer’s Disease
Those in the early stages of Alzheimer’s disease experience a slight but noticeable and measurable decline in cognitive abilities. The difference is found in memory, thinking, language, and judgment skills.
If you have early Alzheimer’s disease, you may have noticed changes in these areas, but the changes have not become severe enough to drastically interrupt daily life.1
One of the hallmarks of early Alzheimer’s disease is the collection and abnormal buildup of two misfolded proteins in the brain. Inflammation may be one other factor associated with early Alzheimer’s disease.
Approximately 15% to 20% of people aged 65 or older have mild cognitive impairment (MCI), an indicator of early Alzheimer’s disease.
Among those with MCI, about one-third (32%) develop early Alzheimer’s disease within 5 years.
The risk factors most strongly linked to early Alzheimer’s disease are advancing age, family history of Alzheimer’s or another dementia, and conditions that raise risk for cardiovascular disease.
Join us on a journey to find answers for early Alzheimer’s disease through clinical research studies.
We need clinical research studies to find safe and effective treatment options for everyone affected by early Alzheimer’s disease. This is where the evoke studies come in.